Resuscitative endovascular balloon occlusion of the aorta (REBOA) in patients with major trauma and uncontrolled haemorrhagic shock: a systematic review with meta-analysis
-
Published:2021-08-12
Issue:1
Volume:16
Page:
-
ISSN:1749-7922
-
Container-title:World Journal of Emergency Surgery
-
language:en
-
Short-container-title:World J Emerg Surg
Author:
Castellini Greta, Gianola SilviaORCID, Biffi Annalisa, Porcu Gloria, Fabbri Andrea, Ruggieri Maria Pia, Coniglio Carlo, Napoletano Antonello, Coclite Daniela, D’Angelo Daniela, Fauci Alice Josephine, Iacorossi Laura, Latina Roberto, Salomone Katia, Gupta Shailvi, Iannone Primiano, Chiara Osvaldo, Stocchetti Nino, De Blasio Elvio, Flego Gaddo, Geraci Massimo, Maccauro Giulio, Rampoldi Antonio, Santolini Federico, Tacconi Claudio, Tugnoli Gregorio,
Abstract
Abstract
Background
Multiple studies regarding the use of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) in patients with non-compressible torso injuries and uncontrolled haemorrhagic shock were recently published. To date, the clinical evidence of the efficacy of REBOA is still debated. We aimed to conduct a systematic review assessing the clinical efficacy and safety of REBOA in patients with major trauma and uncontrolled haemorrhagic shock.
Methods
We systematically searched MEDLINE (PubMed), EMBASE and CENTRAL up to June 2020. All randomized controlled trials and observational studies that investigated the use of REBOA compared to resuscitative thoracotomy (RT) with/without REBOA or no-REBOA were eligible.
We followed the PRISMA and MOOSE guidelines. Two authors independently extracted data and appraised the risk of bias of included studies. Effect sizes were pooled in a meta-analysis using random-effects models. The quality of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation methodology. Primary outcomes were mortality, volume of infused blood components, health-related quality of life, time to haemorrhage control and any adverse effects. Secondary outcomes were improvement in haemodynamic status and failure/success of REBOA technique.
Results
We included 11 studies (5866 participants) ranging from fair to good quality. REBOA was associated with lower mortality when compared to RT (aOR 0.38; 95% CI 0.20–0.74), whereas no difference was observed when REBOA was compared to no-REBOA (aOR 1.40; 95% CI 0.79–2.46). No significant difference in health-related quality of life between REBOA and RT (p = 0.766). The most commonly reported complications were amputation, haematoma and pseudoaneurysm. Sparse data and heterogeneity of reporting for all other outcomes prevented any estimate.
Conclusions
Our findings on overall mortality suggest a positive effect of REBOA among non-compressible torso injuries when compared to RT but no differences compared to no-REBOA. Variability in indications and patient characteristics prevents any conclusion deserving further investigation. REBOA should be promoted in specific training programs in an experimental setting in order to test its effectiveness and a randomized trial should be planned.
Funder
Istituto Superiore di Sanità
Publisher
Springer Science and Business Media LLC
Subject
Emergency Medicine,Surgery
Reference52 articles.
1. Andres J, Scott J, Giannoudis PV. Resuscitative endovascular balloon occlusion of the aorta (REBOA): what have we learned? Injury. 2016;47(12):2603–5. 2. Rotondo MF, Schwab CW, McGonigal MD, Phillips GR 3rd, Fruchterman TM, Kauder DR, et al. 'Damage control': an approach for improved survival in exsanguinating penetrating abdominal injury. J Trauma. 1993;35(3):375–82 discussion 82-3. 3. Biffl WL, Fox CJ, Moore EE. The role of REBOA in the control of exsanguinating torso hemorrhage. J Trauma Acute Care Surgery. 2015;78(5):1054–8. 4. Cannon J, Morrison J, Lauer C, Grabo D, Polk T, Blackbourne L, et al. Resuscitative endovascular balloon occlusion of the aorta (REBOA) for hemorrhagic shock. Mil Med. 2018;183(suppl_2):55–9. 5. McGreevy DT, Sadeghi M, Pirouzram A, Toivola A, Dogan EM, Larzon T, et al. Feasibility and clinical outcome of Reboa in patients with impending traumatic cardiac arrest. Shock. 2019;16:1540–0514.
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|